Abstract

The coronavirus pandemic caused global devastation and put unprecedented pressure on health care facilities world-wide. The response to the pandemic differed across the world as countries faced different challenges. Due to the novelty of this virus and its global effects, published guidance is currently limited to best practice and small-scale trials, however, globally, large-scale clinical trials are now underway. This review summarises the international response to coronavirus with respect to gynaecological oncology and suggests potential interventions to limit its spread during a resurgence or in the event of a future global pandemic.